In Week of Mar 28, 2026, Park Medi World Ltd (Hospitals/Medical Services) is outperforming Nifty 500 with +49.1% relative strength. Fundamentals: Weak.
Weekly presence in the outperformers list. Green = beating Nifty 500 by 10%+ that week.
Based on Q3 FY26 earnings • Updated Mar 21, 2026
What: Adding 660 beds in FY26 with Agra 360-bed facility starting in February 2026
Impact: +₹300 Cr revenue
“We aim to add 660 beds in FY26, 500 in FY27, and 850 in FY28, bringing the total bed count to approximately 5,260”
What: Neurointervention and cardiac services driving ARPOB from ₹25,500 to ₹27,406
Impact: +₹150 Cr revenue
“ARPOB increased to ₹27,406 from ₹25,500 through improved product mix”
What: Complete debt reduction improving PAT through interest cost savings
“We expect to be debt-free by end of February”
Earnings deceleration risks from management commentary
Trigger: Sustained salary increases above 5% quarterly
Impact: -100 bps margin impact
Management view: Competition fee for doctors and doctor salary increased by 8% on Q2
Monitor: QoQ doctor salary growth
Trigger: Occupancy below 60% at acquired facilities
Impact: -150 bps margin impact
Management view: Ongoing integration of recently acquired hospitals
Monitor: Occupancy rates at new facilities
Key quotes from recent conference calls
“We aim to add 660 beds in FY26, 500 in FY27, and 850 in FY28, bringing the total bed count to approximately 5,260 — Management”
“EBITDA for Q3 FY26 was ₹99.4 crore with a 24% margin, and for the nine months, it was ₹317 crore with a 26% margin — CFO”
“Average occupancy across the network improved to approximately 65% during 9 months FY26 — CFO”
“Future financial targets include maintaining an EBITDA of 27%, PAT of 17%, and annualized ROCE of 21% — Management”
Forward-looking targets from management for next 2-4 quarters
Revenue Growth Target
17%
Implied PAT Growth
20%
OPM Guidance
27%
Capex Plan
₹1200 Cr
Key Milestones
• Debt-free by February 2026
• 5,260 beds by FY28
• 27% EBITDA margin
Revenue, profit and margin growth rates
| Metric | YoY | 3Y CAGR | Trend |
|---|---|---|---|
| Revenue | +18% | +9% | Insufficient Data |
| PAT (Net Profit) | +15% | +2% | Insufficient Data |
| OPM | 24.0% | 0 bps | Insufficient Data |
The above analysis is parsed from publicly available earnings call transcripts. This is educational research only — not investment advice. Last updated Mar 21, 2026.
Based on publicly available financial data. This is educational research, not investment advice.
Park Medi World Ltd's latest quarterly results (Dec 2025) show
Park Medi World Ltd's profit is growing with an insufficient_data trend.
Park Medi World Ltd's revenue growth trend is insufficient_data.
Park Medi World Ltd's operating margin is insufficient_data.
Park Medi World Ltd's long-term compounding rates
Park Medi World Ltd's earnings growth is insufficient_data with insufficient_data on a sequential basis.
Park Medi World Ltd appears overvalued based on our fair value analysis.
Park Medi World Ltd's current PE ratio is 40.8x.
Park Medi World Ltd's current PE is 40.8x.
Park Medi World Ltd is rated Weak with a fundamental score of 26.67/100. This score is calculated from objective financial metrics
Park Medi World Ltd has a debt-to-equity ratio of N/A.
Park Medi World Ltd's return ratios over recent years
Park Medi World Ltd's operating cash flow is positive (FY2025).
Park Medi World Ltd currently does not pay a significant dividend (yield 0.00%).
Park Medi World Ltd's shareholding pattern (Dec 2025)
Park Medi World Ltd has been outperforming Nifty 500 for 2 consecutive weeks, indicating early-stage outperformance.
Park Medi World Ltd is an established outperformer with 2 weeks of consecutive Nifty 500 outperformance.
Park Medi World Ltd has 3 key growth catalysts identified from recent earnings analysis
Park Medi World Ltd has 2 key risks worth monitoring
In Q3 FY26, Park Medi World Ltd's management highlighted
Park Medi World Ltd's management has provided the following forward guidance for next 2-4 quarters
Based on quantitative research signals, here is why Park Medi World Ltd may be worth studying
Park Medi World Ltd investment thesis summary:
Park Medi World Ltd's forward outlook based on current data signals
The above FAQs are generated from publicly available earnings data and conference call transcripts. This is educational research only. Sector Alpha is not SEBI registered and does not provide investment advice.
